INTERNATIONAL PATENT: TYRA BIOSCIENCES, INC. FILES APPLICATION FOR "COMBINATION OF THE FGFR 3 INHIBITOR TYRA-300 AND A NECTIN-4 TARGETING AGENT-DRUG CONJUGATE FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Aug. 19 -- TYRA BIOSCIENCES, INC. (2656 State StreetCarlsbad, California 92008) filed a patent application (PCT/US2025/014534) for "COMBINATION OF THE FGFR 3 INHIBITOR TYRA-300 AND A NECTIN-4 TARGETING AGENT-DRUG CONJUGATE FOR USE IN THE TREATMENT OF CANCER" on Feb 05, 2025. With publication no. WO/2025/170959, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STARRETT, Jacqueline (c/o Tyra Biosciences2656 State StreetCarlsbad, California 92008), SWANSON, Ronald (c/o Tyra Biosciences2656 State StreetCarlsbad, Califo...